Losmina

Losmina (Enoxaparin Sodium) is an anticoagulant used to prevent and treat blood clots. It is commonly administered via subcutaneous injection or during haemodialysis.

Losmina is primarily used to prevent and treat blood clots in various medical conditions. It is often prescribed for patients undergoing haemodialysis to maintain blood flow and prevent clotting in the dialysis circuit. Additionally, it may be used to reduce the risk of deep vein thrombosis and pulmonary embolism in certain high-risk individuals.

Common effects of Losmina may include bruising, bleeding, and pain or irritation at the injection site. Some users may experience allergic reactions, though these are less frequent. It is important to monitor for signs of unusual bleeding or bruising.

Losmina should be handled with care to avoid contamination. It is essential to follow proper injection techniques and dispose of needles safely. Patients with a history of bleeding disorders or allergies to heparin or similar medications should consult their healthcare provider before use.

Losmina may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs), increasing the risk of bleeding. Alcohol consumption should be moderated, as it can also affect blood clotting. Always inform your healthcare provider about all medications you are taking.